Key facts
- Notable investors include Bossa Invest, ACE Ventures (Commercial Services), Artemisia, Biominas Brasil, Eretz.Bio — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Salvus
- ·The full record, as it builds
Funding rounds
No funding rounds for Salvus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Salvus
Developer of a home care technology platform designed to help and boost the transformations that the health sector needs. The company offers increased safety, quality, scale, and profitability in futuristic home care support, enabling home care companies to connect healthcare to IoT devices and get refined clinical and financial performance.
- Sector
- Healthcare
- HQ
- Recife, Brazil
- Founded
- 2016
- Employees
- 20
- Website
- salvus.me/
- Ownership
- Privately Held (backing)
Salvus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Salvus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Salvus in its N-PORT filings yet. We sweep new filings monthly.